Search
for
Sort by
Research 871–900 of 1000+
- 075 Clinical investigation of JAK inhibitor Tofacitinib in scarring alopecias
- A clinical and diagnostic approach of a dog with hyperadrenocorticism and hypothyroidism related: Case report
- Efficacy of Kasisadi lepa in Darunaka: A Clinical Case Report
- BaldGraphFormer: An Explainable Deep Learning Framework for Early Baldness Prediction by Integrating Swin Transformer, Graph Attention Networks and Clinical Features
- Exploring the Efficacy and Safety of Topical Phenytoin in Androgenetic Alopecia: A Clinical Investigation
- The Predictive Value of Clinical Hirsutism for Biochemical Hyperandrogenism in a Large Endocrine Referral Cohort
- A clinical investigation using reflectance confocal microscopy to evaluate the add-on efficacy of the Shumin treatment instrument combined with doxycycline for rosacea
- The global clinical landscape of human-derived extracellular vesicles: an analysis based on ClinicalTrials.gov (2010–2025)
- CLINICAL AND DIAGNOSTIC INSIGHTS INTO HYPOTHYROIDISM IN A SHIH-TZU – A CASE REPORT
- CLINICAL MANAGEMENT OF PEMPHIGUS USING AZATHIOPRINE IN A LABRADOR RETRIEVER
- Exosome-Based Therapies for Alopecia: A Systematic Review of Clinical Efficacy and Safety
- Clinical efficacy of Tryushana Churna in management of Hypothyroidism
- Major clinical and nutrological findings of the relationship among obesity, metabolic syndrome, and bariatric surgery in the process of hair loss: a systematic review
- BROCQ’S PSEUDOPELADE DEVELOPED AFTER CHILDBIRTH – CLINICAL CASE
- Clinical and genetic predictors of persistent chemotherapy-induced alopecia despite scalp cooling in breast cancer
- Updated Integrated Safety Analysis of Ritlecitinib up to ~5 Years in Adolescents With Alopecia Areata From the ALLEGRO Clinical Trials
- Long-Term Efficacy and Complete Scalp Hair Regrowth in Patients With Alopecia Areata Receiving Ritlecitinib 50 mg QD Up to 3 Years in the ALLEGRO Clinical Trial Program
- Updated Integrated Safety Analysis of Ritlecitinib Over 72 Months In Patients With Alopecia Areata From the ALLEGRO Clinical Trial Program
- 0475 High-dose UVA-1 therapy improves patient-reported outcomes and clinical scores in patients with sclerosing skin disease
- COLLAB: A Global Survey of Clinical and Laboratory Assessment in Alopecia Areata by Hair Specialists
- Glabellar clinical and trichoscopic findings in patients with frontal fibrosing alopecia
- Exploring Clinical and Imaging Differences in COVID-19: an Observational Approach to the IFITM3 rs12252 Polymorphism
- Secondary Amenorrhea and Clinical Hyperandrogenism in a 34-Year-Old Female: Polycystic Ovary Syndrome or Not?
- First clinical cases of leishmaniosis in meerkats (Suricata suricatta) housed in wildlife parks in Madrid, Spain
- Musculoskeletal and body composition response to high-dose testosterone with finasteride after chronic incomplete spinal cord injury—a randomized, double-blind, and placebo-controlled pilot study
- Clinical, Laboratory, and Trichoscopic Features of Pediatric Androgenetic Alopecia
- Worldwide Clinical and Real-World Exposure to Baricitinib
- Successful Dupilumab Administration in Adolescent with Alopecia Areata and Atopic Dermatitis: Clinical Case
- Characterizing Clinical and Hormonal Profiles of Acne in North African Women with Polycystic Ovary Syndrome
- 53289 Clinical and metabolic characteristics of male patients with early-onset androgenetic alopecia: A possible predisposition to metabolic syndrome